Does early regional analgesia during labor really raise the risk of C/S, compared to early systemic analgesia? The authors believe their randomized controlled trial definitively answers that question.
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More